A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer

Cancer Medicine ◽

10.1002/cam4.447 ◽

2015 ◽

Vol 4 (7) ◽

pp. 1051-1059 ◽

Author(s):

Pavani Chalasani ◽

Marilyn Marron ◽

Denise Roe ◽

Kathryn Clarke ◽

Maria Iannone ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase I ◽

Metastatic Breast ◽

Phase I Clinical Trial

Download Full-text

116 A phase I clinical trial to evaluate the pharmacokinetics, toxicity and dosimetry of 111-indium-labeled human epidermal growth factor in patients with metastatic breast cancer

Radiotherapy and Oncology ◽

10.1016/s0167-8140(05)80277-4 ◽

2005 ◽

Vol 76 ◽

pp. S35

Author(s):

K. Vallis ◽

R. Reilley ◽

D. Scollard ◽

J. Petronis ◽

C. Caldwell ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Metastatic Breast ◽

Phase I Clinical Trial ◽

Human Epidermal Growth Factor ◽

Epidermal Growth

Download Full-text

Multicenter phase I clinical trial of daily and weekly RAD001 in combination with vinorelbine and trastuzumab in patients with HER2-overexpressing metastatic breast cancer with prior resistance to trastuzumab

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.1057 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 1057-1057 ◽

Author(s):

G. H. Jerusalem ◽

V. Dieras ◽

F. Cardoso ◽

J. Bergh ◽

A. Fasolo ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase I ◽

Metastatic Breast ◽

Phase I Clinical Trial ◽

Multicenter Phase

Download Full-text

5004 Multicenter phase I clinical trial of daily and weekly everolimus (RAD001) in combination with vinorelbine and trastuzumab in patients with HER-2-overexpressing metastatic breast cancer (MBC) with prior resistance to trastuzumab

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)70896-1 ◽

2009 ◽

Vol 7 (2) ◽

pp. 261 ◽

Author(s):

F. Cardoso ◽

L. Gianni ◽

G. Jerusalem ◽

A. Fasolo ◽

J. Bergh ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase I ◽

Metastatic Breast ◽

Phase I Clinical Trial ◽

Multicenter Phase ◽

Download Full-text

RAD001 (everolimus) in combination with weekly paclitaxel and trastuzumab in patients with HER-2-overexpressing metastatic breast cancer with prior resistance to trastuzumab: a multicenter phase I clinical trial.

10.1158/0008-5472.sabcs-3119 ◽

2009 ◽

Author(s):

R O'Regan ◽

F Andre ◽

M Campone ◽

M Naughton ◽

C Manlius ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase I ◽

Metastatic Breast ◽

Phase I Clinical Trial ◽

Weekly Paclitaxel ◽

Multicenter Phase ◽

Download Full-text

A Phase I Clinical Trial of a Combination of Mitoxantrone, 5-Fluorouracil, and High-Dose Leucovorin Given on a Day 1 and Day 8 Schedule to Patients with Metastatic Breast Cancer

American Journal of Clinical Oncology ◽

10.1097/00000421-199402000-00010 ◽

1994 ◽

Vol 17 (1) ◽

pp. 45-49 ◽

Author(s):

Charles L. Vogel ◽

Eduardo G. Gomez

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase I ◽

Metastatic Breast ◽

Phase I Clinical Trial ◽

Download Full-text

Multicenter phase I clinical trial of daily and weekly RAD001 in combination with weekly paclitaxel and trastuzumab in patients with HER2-overexpressing metastatic breast cancer with prior resistance to trastuzumab

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.1003 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 1003-1003 ◽

Author(s):

F. André ◽

M. Campone ◽

S. A. Hurvitz ◽

L. Vittori ◽

I. Pylvaenaeinen ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase I ◽

Metastatic Breast ◽

Phase I Clinical Trial ◽

Weekly Paclitaxel ◽

Multicenter Phase

Download Full-text

Multicenter phase I clinical trial of daily and weekly RAD001 (everolimus) in combination with vinorelbine and trastuzumab in patients with HER-2-overexpressing metastatic breast cancer with prior resistance to trastuzumab.

10.1158/0008-5472.sabcs-406 ◽

2009 ◽

Author(s):

A Fasolo ◽

L Gianni ◽

A Rorive ◽

J Bergh ◽

V Dieras ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase I ◽

Metastatic Breast ◽

Phase I Clinical Trial ◽

Multicenter Phase ◽

Download Full-text

Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-18-4173 ◽

2019 ◽

Vol 25 (17) ◽

pp. 5212-5220 ◽

Author(s):

Qiao Li ◽

Xiuwen Guan ◽

Shanshan Chen ◽

Zongbi Yi ◽

Bo Lan ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase I ◽

Cancer Patients ◽

Metastatic Breast ◽

Phase I Clinical Trial ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Biomarker Analysis

Download Full-text

5021 Everolimus (RAD001) in combination with weekly paclitaxel and trastuzumab in patients (pts) with HER-2-overexpressing metastatic breast cancer (MBC) with prior resistance to trastuzumab: a multicenter phase I clinical trial

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)70913-9 ◽

2009 ◽

Vol 7 (2) ◽

pp. 267 ◽

Author(s):

S. Hurvitz ◽

R. O'Regan ◽

M. Campone ◽

C. Manlius ◽

L. Vittori ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase I ◽

Metastatic Breast ◽

Phase I Clinical Trial ◽

Weekly Paclitaxel ◽

Multicenter Phase ◽

Download Full-text

Results of a multicenter double-blind phase I clinical trial of using of BCD-022 compared with Herceptin, used in combination with paclitaxel in patients with metastatic breast cancer

Malignant tumours ◽

10.18027/2224-5057-2014-4-62-70 ◽

2015 ◽

pp. 62

Author(s):

E. O. Ignatova ◽

M. A. Frolova ◽

O. N. Burdaeva ◽

M. N. Nechaeva ◽

A. P. Pechenyj ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Phase I ◽

Metastatic Breast ◽

Phase I Clinical Trial ◽

Download Full-text